High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment

Multiple myeloma (MM) is a genetically heterogeneous disease that includes a subgroup of 10–15% of patients facing dismal survival despite the most intensive treatment. Despite improvements in biological knowledge, MM is still an incurable neoplasia, and therapeutic options able to overcome the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Solimando, Antonio Giovanni, Da Vià, Matteo Claudio, Cicco, Sebastiano, Leone, Patrizia, Di Lernia, Giuseppe, Giannico, Donato, Desantis, Vanessa, Frassanito, Maria Antonia, Morizio, Arcangelo, Delgado Tascon, Julia, Melaccio, Assunta, Saltarella, Ilaria, Ranieri, Giuseppe, Ria, Roberto, Rasche, Leo, Kortüm, K. Martin, Beilhack, Andreas, Racanelli, Vito, Vacca, Angelo, Einsele, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678140/
https://www.ncbi.nlm.nih.gov/pubmed/31323969
http://dx.doi.org/10.3390/jcm8070997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678140/
https://www.ncbi.nlm.nih.gov/pubmed/31323969
http://dx.doi.org/10.3390/jcm8070997

Ejemplares similares